financetom
Business
financetom
/
Business
/
Water technology firm Ecolab forecasts upbeat 2025 profit on resilient demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Water technology firm Ecolab forecasts upbeat 2025 profit on resilient demand
Feb 11, 2025 6:41 AM

Feb 11 (Reuters) - Ecolab ( ECL ) on Tuesday forecast

higher-than-expected adjusted profit for 2025 and beat

fourth-quarter profit estimates, helped by resilient demand for

its services such as water treatment, cleaning and sanitization.

The company's shares rose 4.5% in premarket trading.

Ecolab ( ECL ) posted better-than-expected results despite U.S.

manufacturing activity contracting further in December after

falls in November and October.

"Growth in the United States, our largest and most

profitable region, continues to be very strong, and growth

across the rest of the world is solid as we more than offset

uneven macroeconomic trends," CEO Christophe Beck said.

The company forecast adjusted profit between $7.42 per share

and $7.62 per share in 2025, compared with analysts' average

estimate of $7.40 per share, according to data compiled by LSEG.

Beck said that in 2025, the company hopes to grow its sales

to data center, microelectronic, life science and digital

businesses.

In the October-December quarter, the company's biggest

segment, global industrial, which provides water treatment and

cleaning products and services to large industrial customers,

saw a 10.8% rise in operating income to $374.6 million.

Operating income in its global institutional and specialty

segment, which makes cleaning and sanitizing products for

customers such as quick-serving restaurant chains and food

retailers, grew 18.5% from a year ago to $288.4 million.

The Saint Paul, Minnesota-based company posted an

adjusted profit of $1.81 per share for the quarter ended

December 31, compared with analysts' estimate of $1.79 per

share.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Upstart Holdings Insider Sold Shares Worth $343,059, According to a Recent SEC Filing
Upstart Holdings Insider Sold Shares Worth $343,059, According to a Recent SEC Filing
Sep 4, 2025
05:51 PM EDT, 09/04/2025 (MT Newswires) -- Paul Gu, Director, Chief Technology Officer, on September 02, 2025, sold 5,000 shares in Upstart Holdings ( UPST ) for $343,059. Following the Form 4 filing with the SEC, Gu has control over a total of 1,147,156 common shares of the company, with 1,147,156 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1647639/000164763925000118/xslF345X05/wk-form4_1757022497.xml ...
Sweetgreen Names New CFO
Sweetgreen Names New CFO
Sep 4, 2025
05:46 PM EDT, 09/04/2025 (MT Newswires) -- Sweetgreen ( SG ) said late Thursday it has named Jamie McConnell as its chief financial officer, starting Sept. 22. McConnell will succeed Mitch Reback, who is retiring on Sept. 21, the firm said. Reback will retain an advisory role for six months to ensure a smooth transition. McConnell most recently served as...
Irth Capital raising assets for constructivist fund, Abbot to lead effort
Irth Capital raising assets for constructivist fund, Abbot to lead effort
Sep 4, 2025
NEW YORK, Sept 4 (Reuters) - Irth Capital Management, the global alternative asset management firm that invests in both public and private equity, plans to raise a new investment vehicle with the goal of gently but firmly influencing companies, two sources told Reuters. The new vehicle aims to become a constructivist hedge fund where the team will pursue a strategy...
Halozyme Therapeutics Insider Sold Shares Worth $4,444,626, According to a Recent SEC Filing
Halozyme Therapeutics Insider Sold Shares Worth $4,444,626, According to a Recent SEC Filing
Sep 4, 2025
05:46 PM EDT, 09/04/2025 (MT Newswires) -- Helen Torley, Director, President and CEO, on September 02, 2025, sold 60,000 shares in Halozyme Therapeutics ( HALO ) for $4,444,626. Following the Form 4 filing with the SEC, Torley has control over a total of 733,719 common shares of the company, with 733,719 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000141588925023720/xslF345X05/form4-09042025_090922.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved